A brief history of antidepressant drug development: from tricyclics to beyond ketamine
出版年份 2018 全文链接
标题
A brief history of antidepressant drug development: from tricyclics to beyond ketamine
作者
关键词
-
出版物
ACTA NEUROPSYCHIATRICA
Volume -, Issue -, Pages 1-16
出版商
Cambridge University Press (CUP)
发表日期
2018-02-01
DOI
10.1017/neu.2017.39
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders
- (2017) Samuel T. Wilkinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders
- (2017) C A Zarate et al. MOLECULAR PSYCHIATRY
- New targets for rapid antidepressant action
- (2017) Rodrigo Machado-Vieira et al. PROGRESS IN NEUROBIOLOGY
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice
- (2016) Lakshmi Rajagopal et al. BEHAVIOURAL BRAIN RESEARCH
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
- (2016) Chadi G. Abdallah et al. DEPRESSION AND ANXIETY
- Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
- (2016) Ewa Poleszak et al. METABOLIC BRAIN DISEASE
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders
- (2016) G Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant drug action — From rapid changes on network function to network rewiring
- (2016) Tomi Rantamäki et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review
- (2016) Kristian Gaarn du Jardin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism
- (2015) Carly Kiselycznyk et al. BEHAVIOURAL BRAIN RESEARCH
- Atypical Neurotransmitters and the Neurobiology of Depression
- (2015) Samia Joca et al. CNS & Neurological Disorders-Drug Targets
- Recent insights into the mode of action of memantine and ketamine
- (2015) Jon W Johnson et al. CURRENT OPINION IN PHARMACOLOGY
- Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
- (2015) SHELDON PRESKORN et al. Journal of Psychiatric Practice
- Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor
- (2015) Kinga Sałat et al. NEUROPHARMACOLOGY
- Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains
- (2015) Michael R Weed et al. NEUROPSYCHOPHARMACOLOGY
- The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus
- (2015) J. Burgdorf et al. NEUROSCIENCE
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Ketamine and other potential glutamate antidepressants
- (2015) Arpan Dutta et al. PSYCHIATRY RESEARCH
- Antidepressant-like effects induced by NMDA receptor blockade and NO synthesis inhibition in the ventral medial prefrontal cortex of rats exposed to the forced swim test
- (2015) Vitor Silva Pereira et al. PSYCHOPHARMACOLOGY
- Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression
- (2014) Nico Liebenberg et al. ACTA NEUROPSYCHIATRICA
- Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
- (2014) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- New paradigms for treatment-resistant depression
- (2013) Carlos Zarate et al. Annals of the New York Academy of Sciences
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- Ketamine in Pain Management
- (2013) Jan Persson CNS Neuroscience & Therapeutics
- From “Special K” to “Special M”: The Evolution of the Recreational Use of Ketamine and Methoxetamine
- (2013) Ornella Corazza et al. CNS Neuroscience & Therapeutics
- Tropisetron attenuates amyloid-beta-induced inflammatory and apoptotic responses in rats
- (2013) Reza Rahimian et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: Involvement of nitric oxide
- (2013) Vitor S. Pereira et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- mTOR complexes in neurodevelopmental and neuropsychiatric disorders
- (2013) Mauro Costa-Mattioli et al. NATURE NEUROSCIENCE
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
- (2013) Pierre Paoletti et al. NATURE REVIEWS NEUROSCIENCE
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
- (2013) Rong-Jian Liu et al. NEUROPSYCHOPHARMACOLOGY
- Inhibition of the l-arginine–nitric oxide pathway mediates the antidepressant effects of ketamine in rats in the forced swimming test
- (2013) Guang-Fen Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
- (2013) Xian-Cang Ma et al. PLoS One
- Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain
- (2013) Juan M. Lima-Ojeda et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients
- (2013) Kari R. Nations et al. Drugs in research & development
- Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression
- (2012) Xiaochen Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
- (2012) Kari R Nations et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
- (2011) Rong-Jian Liu et al. BIOLOGICAL PSYCHIATRY
- Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
- (2011) E Beurel et al. MOLECULAR PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Potential therapeutic uses of BDNF in neurological and psychiatric disorders
- (2011) Alan H. Nagahara et al. NATURE REVIEWS DRUG DISCOVERY
- Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels
- (2011) Alessandro Barbon et al. NEUROCHEMISTRY INTERNATIONAL
- The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice
- (2011) Jesse S.O. Lindholm et al. NEUROPHARMACOLOGY
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
- (2010) Severine Farley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Chronic ketamine use increases serum levels of brain-derived neurotrophic factor
- (2010) Valerio Ricci et al. PSYCHOPHARMACOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today
- (2009) Francisco Lopez-Munoz et al. CURRENT PHARMACEUTICAL DESIGN
- CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls
- (2009) Francisco A. Moreno et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Half a Century of Antidepressant Drugs
- (2009) Peter Fangmann et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation
- (2009) H. Jourdi et al. JOURNAL OF NEUROSCIENCE
- The N-methyl-d-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats
- (2009) Jeffrey Burgdorf et al. NEUROBIOLOGY OF AGING
- Glutamate-based antidepressants: 20 years on
- (2009) Phil Skolnick et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The effect of MK-801 on mTOR/p70S6K and translation-related proteins in rat frontal cortex
- (2008) Se Chang Yoon et al. NEUROSCIENCE LETTERS
- Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice
- (2008) Oguz Mutlu et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
- Do ATP and NO interact in the CNS?
- (2007) F. Florenzano et al. PROGRESS IN NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started